by Shahid Ali, MD; Shagufta Jabeen, MD; Rebecca J. Pate, MD; Marwah Shahid, MS; Sandhya Chinala, MD; Milankumar Nathani, MD; and Rida Shah, MD Drs. Ali, Chinala, Nathani, and Shah
by Muruga A. Loganathan, MD; Manasa Enja, MD; and Steven Lippmann, MD Dr. Loganathan is a resident in the Department of Psychiatry, Allegheny General Hospital, Pittsburgh, Pennsylvania; Dr. Enja is
Dear Editor: Multiple sclerosis (MS) is a relatively frequent inflammatory autoimmune illness of the central nervous system affecting about 2.5 million people around the world and representing the most common
Dear Editor: Atypical long-acting injectable (LAI) antipsychotics may improve treatment options for patients with serious mental illnesses, such as schizophrenia and bipolar disorder.[1] A systematic review of 1,700 outpatients from
The latest in neuroscience—sorted and summarized for you Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
Innov Clin Neurosci. 2015;12(5–6 Suppl B):3–19. CNS Drug Compounds/Therapies/Devices Long-acting injectable antipsychotics (LAIs) in outpatient treatment of DMS-IV-R schizophrenia Presenters: Bellnier T, Patil K, Ortega T, Seeger G Affiliations: SUNY
by Murali K. Kolikonda, MD; Suneela Cherlopalle, MD; Manasa Enja, MD; and Steven Lippmann, MD Drs. Kolikonda, Cherlopalle, Enja, and Lippmann are with the University of Louisville School of Medicine,
by Mitali Wadekar, MD; Anil Sharma, MD, MBA; and Gina Battaglia, PhD Drs. Wadekar and Sharma are with IRB Company, Inc., Buena Park, California, and Dr. Bittaglia is an independent
by Steven T. Szabo, MD, PhD; Bruce J. Kinon, MD; Stephen K. Brannan, MD; Andrew K. Krystal, MD, MSc; Joop M A van Gerven, MD, PhD; Atul Mahableshwarkar, MD; and
by Rocco S. Calabrò, MD, PhD; Placido Bramanti, MD; Annalisa Baglieri, PsyD, PhD; Francesco Corallo, PsyD; Rosaria De Luca, MSc, PhD; Simona De Salvo, MSc; Silvia Marino, MD, PhD All
by The CNS Summit Rater Training and Certification Committee: Mark D. West; David G. Daniel, MD; Mark Opler, PhD, MPH; Alexandria Wise-Rankovic, PhD; and Amir Kalali, MD Mr. West is
by Julie P. Gentile, MD; Paulette Marie Gillig, MD, PhD; Kelly Stinson, MD; and Jeremy Jensen, MD Dr. Gentile is Professor, Department of Psychiatry, Wright State University, Dayton, Ohio; Dr.
by Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; and Gholamreza Azizi Dr. Mirshafiey is from the Departmant of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Dr.
by Douglas S. Lehrer, MD, and Jennifer Lorenz, MD Dr. Lehrer is from Wright State University Boonshoft School of Medicine, Department of Psychiatry, Dayton, Ohio, and Summit Behavioral Healthcare, Cincinnati,
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
